ATE556135T1 - Neues protein - Google Patents

Neues protein

Info

Publication number: ATE556135T1
Authority: AT; Austria
Prior art keywords: amino acid; acid sequence; encodes; new protein; protein
Prior art date: 2003-06-16

Application number

AT04746169T

Other languages

English (en)

Inventor

Iichirou Shimomura

Yukio Yamada

Original Assignee

Takeda Pharmaceutical

Iichirou Shimomura

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-16

Filing date

2004-06-15

Publication date

2012-05-15

2004-06-15 Application filed by Takeda Pharmaceutical, Iichirou Shimomura filed Critical Takeda Pharmaceutical

2012-05-15 Application granted granted Critical

2012-05-15 Publication of ATE556135T1 publication Critical patent/ATE556135T1/de

Links

102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
125000003275 alpha amino acid group Chemical group 0.000 abstract 3
102000039446 nucleic acids Human genes 0.000 abstract 2
108020004707 nucleic acids Proteins 0.000 abstract 2
150000007523 nucleic acids Chemical class 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 1
230000004069 differentiation Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000006371 metabolic abnormality Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1
210000002363 skeletal muscle cell Anatomy 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Diabetes (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Biophysics (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT04746169T 2003-06-16 2004-06-15 Neues protein ATE556135T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2003171188		2003-06-16
JP2003391047		2003-11-20
JP2004023557		2004-01-30
JP2004030988		2004-02-06
PCT/JP2004/008699 WO2004111234A1 (ja)	2003-06-16	2004-06-15	新規蛋白質

Publications (1)

Publication Number	Publication Date
ATE556135T1 true ATE556135T1 (de)	2012-05-15

Family

ID=33556542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04746169T ATE556135T1 (de)	2003-06-16	2004-06-15	Neues protein

Country Status (4)

Country	Link
US (1)	US7700361B2 (de)
EP (1)	EP1634951B1 (de)
AT (1)	ATE556135T1 (de)
WO (1)	WO2004111234A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE505480T1 (de)	2001-12-20	2011-04-15	Enobia Pharma Inc	Knochenpolypeptid-1
JP4761812B2 (ja) *	2005-04-18	2011-08-31	武田薬品工業株式会社	マスクリン受容体およびその用途
US7470668B2 (en) *	2005-08-24	2008-12-30	Enobia Pharma Inc.	Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof
EP2067480A4 (de) *	2006-09-30	2009-11-25	Takeda Pharmaceutical	Musclin-rezeptor und seine verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1208100A (en)	1998-10-15	2000-05-01	Genetics Institute Inc.	Secreted expressed sequence tags (sests)
CA2296792A1 (en)	1999-02-26	2000-08-26	Genset S.A.	Expressed sequence tags and encoded human proteins
ATE505480T1 (de)	2001-12-20	2011-04-15	Enobia Pharma Inc	Knochenpolypeptid-1

2004
- 2004-06-15 US US10/561,144 patent/US7700361B2/en not_active Expired - Fee Related
- 2004-06-15 WO PCT/JP2004/008699 patent/WO2004111234A1/ja not_active Ceased
- 2004-06-15 AT AT04746169T patent/ATE556135T1/de active
- 2004-06-15 EP EP04746169A patent/EP1634951B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US7700361B2 (en)	2010-04-20
EP1634951B1 (de)	2012-05-02
WO2004111234A1 (ja)	2004-12-23
EP1634951A1 (de)	2006-03-15
US20070042374A1 (en)	2007-02-22
EP1634951A4 (de)	2006-10-18

Similar Documents

Publication	Publication Date	Title
WO2005003296A3 (en)	2005-04-21	Albumin fusion proteins
TNSN08064A1 (en)	2009-07-14	Albumin fusion proteins
DE602004030464D1 (de)	2011-01-20	Methode zur produktion und evaluierung der zytotoxizität von kir2dl nk-rezeptor antikörpern
WO2005077042A3 (en)	2006-11-30	Albumin fusion proteins
ES2353814T3 (es)	2011-03-07	Proteinas n-glicosiladas recombinantes de celulas procariotas.
NZ591415A (en)	2012-10-26	Haemophilus influenzae type B
ATE368688T1 (de)	2007-08-15	Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
WO2003020932A1 (en)	2003-03-13	Novel secretory proteins and dna thereof
EP1440981A3 (de)	2005-11-23	Vollständige humane cDNS
WO2004053059A3 (en)	2005-05-19	Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same
EA200600042A1 (ru)	2006-08-25	Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах
ATE556135T1 (de)	2012-05-15	Neues protein
EP1978994A4 (de)	2009-05-20	Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
WO2006028561A3 (en)	2007-08-30	Novel purified fabi polypeptides from fransicella tularensis
ATE511644T1 (de)	2011-06-15	Neues screening-verfahren
DE60321443D1 (de)	2008-07-17	Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
WO2005060667A3 (en)	2009-03-19	Nucleic acid and amino acid sequences involved in pain
DK2186898T3 (da)	2015-06-22	Blomstrings-induktion
DE50311090D1 (de)	2009-03-05	Repressor der skelettmuskeldifferenzierung, dafür kodierende nucleinsäure und dessen verwendung in diagnostik und therapie
WO2005079316A3 (en)	2006-01-26	Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
WO2002074793A3 (en)	2004-02-26	Novel peptides for the diagnosis of schizophrenia
ATE455863T1 (de)	2010-02-15	Methoden und zusammensetzungen zur identifikation von gen-funktion
WO2004081165A3 (en)	2004-12-16	Novel purified dihydrodipicolinate synthase polypeptides and structures thereof
WO2004013281A3 (en)	2004-07-01	Novel proteins and their uses
EP1482038A4 (de)	2005-08-17	Neues protein und seine dna